drugset

drugset / Trial / NCT03558425

A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects

NCT03558425 ↗

Phase 1 Completed 41 enrolled Chong Kun Dang Pharmaceutical

RandomizedCrossoverSingle-blindTreatment

Summary

A Study to compare pharmacokinetics and safety of CKD-381 and D026 in healthy subjects

Timeline

Start: 2018-06-27
Primary completion: 2018-09-14
Completion: 2018-09-14

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CKD-381	Unknown	—	—
Subject	D026	Unknown	—	—

Indications